Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024.
"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."
Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month.
The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses.
Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent.
Lauren Forsch, founder of Popped.nyc, stopped by the Cheddar News studio on 4/20 — a date known to many as Cannabis Day — to discuss the health and wellness benefits of CBD-based products.
One of the last major players in the DVD rental business has expressed interest in purchasing Netflix's mailing division, which is now set to be shut down. Bill Rouhana, CEO of Chicken Soup for the Soul Entertainment, which owns Redbox and its network of DVD kiosks, told The Hollywood Reporter that "I'd like to buy it," and that he's reached out multiple times about an acquisition.
Tesla shares fell sharply at the opening bell Thursday after the company felt the sting of numerous price cuts it made across its model line up this year in hopes of energizing sales.
